Lantiseptic by Dermarite Dry Skin Therapy

Product NDC
61924-504
Requested package NDC
61924-504-04
11-digit product format
619240504
Labeler code
61924
Product ID
61924-504_9c5b13c9-23e5-bcdc-e053-2995a90a1d4e
Type
HUMAN OTC DRUG
Nonproprietary name
LANOLIN
Dosage form
CREAM
Route
TOPICAL
Labeler
Dermarite Industries LLC
Application
part347
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2018-12-25
Marketing end
0000-00-00
Substance
LANOLIN
Active strength
300 mg/g
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage61924-50461924-504-04IInactivated by FDA2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 9 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-288af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-081332a3947898…d4bfe170f9cd…
2022-08-30 03:57 UTC · source 2022-08-29fb8cb913e6d1…eb8c232b6be0…
2022-04-09 23:13 UTC · source 2022-04-0886f5da6cb304…a595104c45d7…
2022-04-04 05:40 UTC · source 2022-04-01bd6a592717d7…303034d00443…

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
61924-504-04Lantiseptic by Dermarite Dry Skin Therapy113 g in 1 TUBECREAM1133
61924-504-05Lantiseptic by Dermarite Dry Skin Therapy5 g in 1 PACKETCREAM53
61924-504-14Lantiseptic by Dermarite Dry Skin Therapy14.2 g in 1 PACKETCREAM14.23

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
61924-504LANTISEPTIC BY DERMARITE DRY SKIN THERAPY (LANOLIN) CREAM [DERMARITE INDUSTRIES LLC]3Legacy NDC, 3 package rows20241208_7730af3b-fea2-63ee-e053-2991aa0afe0c.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1657183lanolin 30 % Topical CreamPSN7730af3b-fea2-63ee-e053-2991aa0afe0c3
1657185Lantiseptic 30 % Topical CreamPSN7730af3b-fea2-63ee-e053-2991aa0afe0c3
1657185lanolin 300 MG/ML Topical Cream [Lantiseptic]SBD7730af3b-fea2-63ee-e053-2991aa0afe0c3
1657183lanolin 300 MG/ML Topical CreamSCD7730af3b-fea2-63ee-e053-2991aa0afe0c3
1657183lanolin 30 % Topical CreamSY7730af3b-fea2-63ee-e053-2991aa0afe0c3
1657185Lantiseptic 30 % Topical CreamSY7730af3b-fea2-63ee-e053-2991aa0afe0c3
1657185Lantiseptic 300 MG/ML Topical CreamSY7730af3b-fea2-63ee-e053-2991aa0afe0c3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
61924-504-0461924050404113 g in 1 TUBE (61924-504-04) 113 g2018-12-250000-00-00NoNoCurrent